These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9373887)
1. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression. Abel KM; O'Keane V; Murray RM; Cleare AJ Psychoneuroendocrinology; 1997 Oct; 22(7):539-48. PubMed ID: 9373887 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients. Abel KM; O'Keane V; Murray RM Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429 [TBL] [Abstract][Full Text] [Related]
3. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response. Cleare AJ; Murray RM; O'Keane V Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879 [TBL] [Abstract][Full Text] [Related]
4. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies. Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090 [TBL] [Abstract][Full Text] [Related]
5. Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophrenia. Jones H; Curtis VA; Wright PA; Lucey JV Int Clin Psychopharmacol; 1998 Sep; 13(5):199-203. PubMed ID: 9817624 [TBL] [Abstract][Full Text] [Related]
6. Prolactin and cortisol responses to fenfluramine in Parkinson's disease. Kostić VS; Lecić D; Doder M; Marinković J; Filipović S Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070 [TBL] [Abstract][Full Text] [Related]
7. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. O'Keane V; Dinan TG Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948 [TBL] [Abstract][Full Text] [Related]
8. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge. Gerra G; Fertonani G; Tagliavini P; Zaimovic A; Delsignore R; Maestri D; Avanzini P; Caccavari R; Brambilla F Psychiatry Res; 1995 Sep; 58(2):153-60. PubMed ID: 8570767 [TBL] [Abstract][Full Text] [Related]
9. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048 [TBL] [Abstract][Full Text] [Related]
10. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375 [TBL] [Abstract][Full Text] [Related]
11. Serum cholesterol and serotonergic function in major depressive disorder. Papakostas GI; Petersen T; Mischoulon D; Hughes ME; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M Psychiatry Res; 2003 May; 118(2):137-45. PubMed ID: 12798978 [TBL] [Abstract][Full Text] [Related]
12. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients. Maes M; Jacobs MP; Suy E; Minner B; Raus J Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010 [TBL] [Abstract][Full Text] [Related]
13. Do noradrenergic reuptake inhibitors affect serotonergic function in depression? Cleare AJ; Murray RM; O'Keane V Psychopharmacology (Berl); 1997 Dec; 134(4):406-10. PubMed ID: 9452184 [TBL] [Abstract][Full Text] [Related]
14. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests. Duval F; Mokrani MC; Monreal J; Bailey P; Valdebenito M; Crocq MA; Macher JP Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131 [TBL] [Abstract][Full Text] [Related]
15. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S J Affect Disord; 1999; 52(1-3):121-33. PubMed ID: 10357025 [TBL] [Abstract][Full Text] [Related]
17. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study. Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122 [TBL] [Abstract][Full Text] [Related]
18. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment. O'Keane V; McLoughlin D; Dinan TG J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163 [TBL] [Abstract][Full Text] [Related]
19. Recovery from major depression is not associated with normalization of serotonergic function. Flory JD; Mann JJ; Manuck SB; Muldoon MF Biol Psychiatry; 1998 Mar; 43(5):320-6. PubMed ID: 9513746 [TBL] [Abstract][Full Text] [Related]
20. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder. Coiro V; Volpi R; Marchesi C; De Ferri A; Davoli C; Caffarra P; Rossi G; Caffarri G; Davolio M; Chiodera P Psychoneuroendocrinology; 1993; 18(8):551-6. PubMed ID: 8127946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]